2024-11-19 18:34:59
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
Health/ 2023-07-22
VISEN Pharmaceuticals Receives IND Appro...

SHANGHAI,Jan. 7,2021-- VISEN Pharmaceuticals,a biotech company committed to the treatment of endocrine-related diseases,introducing the worl...

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
Health/ 2023-07-22
Kira Pharmaceuticals Announces $53.5 Mil...

CAMBRIDGE,Mass. and SUZHOU,China,Jan. 7,2021-- Kira Pharmaceuticals,a global biotechnology company pioneering a new generation of complement...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release